Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1 : A Case Presentation and Review of the Literature
The outbreak of COVID-19 pandemia is a major health worldwide concern. Patients with cancer might have a worse outcome, because of the immunosuppression determined by the tumor itself and anti-cancer treatments, including chemotherapy and radiotherapy. The impact and course of viral infection in patients receiving immunotherapy remains unknown. We report the case of a patient with metastatic melanoma, long responder to anti PD-1 blockade who got infected with Sars CoV-2, recovering without sequelae. A critical review of literature was performed. Limited data available in literature support the possibility to continue the immunotherapy in patients with cancer under control.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
---|---|
Enthalten in: |
Cancer investigation - 39(2021), 1 vom: 01. Jan., Seite 9-14 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pala, Laura [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-PD-1 |
---|
Anmerkungen: |
Date Completed 25.01.2021 Date Revised 25.01.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/07357907.2020.1844893 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM316938041 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM316938041 | ||
003 | DE-627 | ||
005 | 20231225162151.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/07357907.2020.1844893 |2 doi | |
028 | 5 | 2 | |a pubmed24n1056.xml |
035 | |a (DE-627)NLM316938041 | ||
035 | |a (NLM)33125301 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pala, Laura |e verfasserin |4 aut | |
245 | 1 | 0 | |a Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1 |b A Case Presentation and Review of the Literature |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.01.2021 | ||
500 | |a Date Revised 25.01.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The outbreak of COVID-19 pandemia is a major health worldwide concern. Patients with cancer might have a worse outcome, because of the immunosuppression determined by the tumor itself and anti-cancer treatments, including chemotherapy and radiotherapy. The impact and course of viral infection in patients receiving immunotherapy remains unknown. We report the case of a patient with metastatic melanoma, long responder to anti PD-1 blockade who got infected with Sars CoV-2, recovering without sequelae. A critical review of literature was performed. Limited data available in literature support the possibility to continue the immunotherapy in patients with cancer under control | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Melanoma | |
650 | 4 | |a anti-PD-1 | |
650 | 4 | |a cancer | |
650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
650 | 7 | |a Antineoplastic Agents, Immunological |2 NLM | |
650 | 7 | |a Immune Checkpoint Inhibitors |2 NLM | |
650 | 7 | |a pembrolizumab |2 NLM | |
650 | 7 | |a DPT0O3T46P |2 NLM | |
700 | 1 | |a Conforti, Fabio |e verfasserin |4 aut | |
700 | 1 | |a Cocorocchio, Emilia |e verfasserin |4 aut | |
700 | 1 | |a Ferrucci, Pierfrancesco |e verfasserin |4 aut | |
700 | 1 | |a De Pas, Martino Tommaso |e verfasserin |4 aut | |
700 | 1 | |a Stucchi, Sara |e verfasserin |4 aut | |
700 | 1 | |a Repetto, Matteo |e verfasserin |4 aut | |
700 | 1 | |a Saponara, Maristella |e verfasserin |4 aut | |
700 | 1 | |a Queirolo, Paola |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancer investigation |d 1985 |g 39(2021), 1 vom: 01. Jan., Seite 9-14 |w (DE-627)NLM012914193 |x 1532-4192 |7 nnns |
773 | 1 | 8 | |g volume:39 |g year:2021 |g number:1 |g day:01 |g month:01 |g pages:9-14 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/07357907.2020.1844893 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 39 |j 2021 |e 1 |b 01 |c 01 |h 9-14 |